A rare mutation in a rare tumor--SMARCB1-deficient malignant glomus tumor

Affiliations

¹ Clinical Oncology Unit, Westpomeranian Cancer Center, Szczecin, Poland.
² Department of Pathology, Westpomeranian Cancer Center, Szczecin, Poland.
³ Radiotherapy Unit, Westpomeranian Cancer Center, Szczecin, Poland.
⁴ Experimental and Clinical Pharmacology Department, Pomeranian Medical University, Szczecin, Poland.
⁵ Oncogene Diagnostics, Cracow, Poland.
⁶ Department of Immunology, Warsaw Medical University, Warsaw, Poland.
⁷ Department of Medical Genetics, Warsaw Medical University, Warszawa, Poland.
⁸ Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.

Comment

Bartosz Dabek et al. Genes Chromosomes Cancer. 2016 Jan.

. 2016 Jan;55(1):107-9.

doi: 10.1002/gcc.22296. Epub 2015 Sep 22.

¹ Clinical Oncology Unit, Westpomeranian Cancer Center, Szczecin, Poland.
² Department of Pathology, Westpomeranian Cancer Center, Szczecin, Poland.
³ Radiotherapy Unit, Westpomeranian Cancer Center, Szczecin, Poland.
⁴ Experimental and Clinical Pharmacology Department, Pomeranian Medical University, Szczecin, Poland.
⁵ Oncogene Diagnostics, Cracow, Poland.
⁶ Department of Immunology, Warsaw Medical University, Warsaw, Poland.
⁷ Department of Medical Genetics, Warsaw Medical University, Warszawa, Poland.
⁸ Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.

No abstract available

Comment on

Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.
Mosquera JM, Sboner A, Zhang L, Chen CL, Sung YS, Chen HW, Agaram NP, Briskin D, Basha BM, Singer S, Rubin MA, Tuschl T, Antonescu CR. Mosquera JM, et al. Genes Chromosomes Cancer. 2013 Nov;52(11):1075-87. doi: 10.1002/gcc.22102. Epub 2013 Sep 2. Genes Chromosomes Cancer. 2013. PMID: 23999936 Free PMC article.